Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2003
06/12/2003WO2003048340A2 Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof
06/12/2003WO2003048334A2 Immunocytokines with modulated selectivity
06/12/2003WO2003048332A2 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS
06/12/2003WO2003048329A2 Chromosomal saturation mutagenesis
06/12/2003WO2003048323A2 Polynucleotides and polypeptides associated with the development of rheumatoid arthritis
06/12/2003WO2003048318A2 Methods for the identification of genetic features
06/12/2003WO2003048314A2 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips
06/12/2003WO2003048310A2 Thermus oshimai nucleic acid polymerases
06/12/2003WO2003048309A2 Thermus thermophilus nucleic acid polymerases
06/12/2003WO2003048304A2 ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF
06/12/2003WO2003048300A2 Methods of identifying cellular target molecules
06/12/2003WO2003048299A2 Novel spore wall proteins and genes from microsporidia
06/12/2003WO2003048295A1 Microfluidic device and methods of using same
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048193A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
06/12/2003WO2003048187A2 Peptides and use thereof in therapeutic agents against hiv infection
06/12/2003WO2003048178A2 Nucleotide analogues and their use for nucleic acid sequencing
06/12/2003WO2003048172A1 Compounds for determining the activity of phospholipase a¿2?
06/12/2003WO2003047738A2 Liquid interface configurations for automated patch clamp recording
06/12/2003WO2003047611A2 Ptp10d, tec and edtp involved in triglycerid-metabolism
06/12/2003WO2003047606A2 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
06/12/2003WO2003047532A2 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
06/12/2003WO2003047509A2 Enzyme activity profiles
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003WO2003047421A2 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003WO2003047420A2 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
06/12/2003WO2003047350A1 Inhibition of vacuolar proton atpase and/or modulation of acidic organelle function sensitizes
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2003020734A3 Labeled nucleoside polyphosphates
06/12/2003WO2003016860A3 Systems and methods for screening pharmaceutical chemicals
06/12/2003WO2003012070A3 Gene associated with bone disorders
06/12/2003WO2002103031A3 Methods for detecting and treating the early onset of aging-related conditions
06/12/2003WO2002100894A3 Dna encoding a mutant peroxisome proliferator-activated receptor gamma coactivator-1 (pgc-1), detection methods and test kits therefor
06/12/2003WO2002057465A3 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
06/12/2003WO2002054044A3 Focused acoustic ejection cell sorting system and method
06/12/2003WO2002018544A3 Method and reagents for treatment of skin disorders by modulating the notch pathway
06/12/2003WO2002008748A9 Ion channel assay methods
06/12/2003WO2001088188A3 Method for examining ischemic conditions
06/12/2003WO2001088126A8 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
06/12/2003WO2001085096A9 Mast cell regulation
06/12/2003WO2001083701A8 Light-driven energy generation using proteorhodopsin
06/12/2003WO2001074405A9 Gene expression profiles in esophageal tissue
06/12/2003WO2001073133A9 Compositions and methods for identifying and targeting cancer cells
06/12/2003WO2001071007A3 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
06/12/2003US20030110529 Genetic engineering gene expression cassette; adjustment protein cell cycles; plants
06/12/2003US20030110526 Dysferlin mutations
06/12/2003US20030110523 Determination genotypes
06/12/2003US20030110519 Cognition activators, sleep disorders, eating disorders, psychological disorders
06/12/2003US20030109690 Colon and colon cancer associated polynucleotides and polypeptides
06/12/2003US20030109685 Schizophrenic, psychological disorders, Parkinson's disease; genetic engineered polypeptide
06/12/2003US20030109675 Therapy for infections; enzyme inhibitors
06/12/2003US20030109674 Antiinflammatory agents; medical diagnosis; genetic engineered polypeptide
06/12/2003US20030109501 High throughput assay for N-sulfotransferase activity of glucosaminyl N-deacetylase/N-sulfotransferases
06/12/2003US20030109500 Compositions and methods for use in targeting vascular destruction
06/12/2003US20030109483 A purified Parapoxvirus ovis envelope protein termed "B2L" can be used as a monotherapeutic agent. B2L protein also can be used in screening methods to identify potential therapeutic agents for modulating a subject's immune response
06/12/2003US20030109481 Tumour-cell specific gene expression and its use in cancer therapy
06/12/2003US20030109477 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
06/12/2003US20030109474 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and
06/12/2003US20030109444 Bone anti-resorptive compounds
06/12/2003US20030109443 Determining the prognosis for treatment of, and methods for identifying candidate compounds for treating, stabilizing, or preventing cancer, for example, endometrial cancer. These methods utilize the novel tumor suppressor protein, Cables.
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109420 Diagnostic markers of acute coronary syndrome and methods of use thereof
06/12/2003US20030109419 Detection and tested for an ability to treat a psychotic disorder in a patient in need of such treatment. The invention provides a method for screening candidate drugs for anti-psychotic drug activity, preferably atypical
06/12/2003US20030109418 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
06/12/2003US20030109057 Apparatus and methods for chemiluminescent assays
06/12/2003US20030109042 Stimulant immunology system; cell differentiation; culture product; three-dimensional support
06/12/2003US20030109039 Enriched central nervous system stem cell and porgenitor cell populations, and methods for identifying, isolating and enriching for such populations
06/12/2003US20030109038 Chondrocyte precursors derived from human embryonic stem cells
06/12/2003US20030109031 System for detecting biological materials in a sample
06/12/2003US20030109022 Asp2
06/12/2003US20030109020 Novel human lysosomal protein and methods of its use
06/12/2003US20030109018 Novel endometriosis-associated gene
06/12/2003US20030109005 Sequence determination; polymerase chain reactions
06/12/2003US20030109004 Culture product; cell transformation; genetic engineering using promoter
06/12/2003US20030109003 Antitumor agent; transformation of expression vector; genetic engineering; process control hybrids
06/12/2003US20030108998 Aggrecan degrading metallo proteases
06/12/2003US20030108983 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030108981 Colorimetric method for detection of dipicolinic acid in mailpieces
06/12/2003US20030108980 Bioluminescent methods for direct visual detection of environmental compounds
06/12/2003US20030108979 Methods for the identification of inhibitors of threonine synthase as antibiotics
06/12/2003US20030108978 Whole cell assay systems for cell surface proteases
06/12/2003US20030108977 Methods for the identification of inhibitors of pyruvate orthophosphate dikinase expression or activity in plants
06/12/2003US20030108971 Enzyme
06/12/2003US20030108969 Screening bactericides; ppetidoglucan biosynthesis; scintillation
06/12/2003US20030108968 Determination lymphocytes to specific antigen in blood
06/12/2003US20030108966 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/12/2003US20030108964 Caspase-inhibitory-factor(cif)and uses thereof
06/12/2003US20030108962 Method of cancer estimation by alp isozymes
06/12/2003US20030108961 Methods and compositions for diagnosing breast cancer
06/12/2003US20030108957 Biocidal molecules, macromolecular targets and methods of production and use
06/12/2003US20030108954 Focusing sound waves
06/12/2003US20030108953 Truncated egf receptor
06/12/2003US20030108948 Artificial antibody polypeptides
06/12/2003US20030108947 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
06/12/2003US20030108943 Heterogeneity mixture of nucleic acids; measurement chromosome breaking; in situ hybridization
06/12/2003US20030108941 Novel cancer drug screen based on cell cycle uncoupling
06/12/2003US20030108940 Novel polymorphic microsatellite markers in the human MHC class II region
06/12/2003US20030108939 In vivo method for identifying target sites for antisense-mediated inhibition of a selected gene
06/12/2003US20030108938 Analyzing phenotypes; computer genotype data base
1 ... 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 ... 3003